Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma
Document Type
Report
Department
Haematology/Oncology
Abstract
Background and objectives: While treatment outcomes for patients with Hodgkin lymphoma (HL) have improved remarkably, patients with disseminated disease still have a poorer outcome. Stage IV HL is often reported with other 'advanced stage' categories, confusing the specific contribution of disease dissemination to the outcome. This single-institution report looks at characteristics and outcomes of this specific category.
Patients and methods: The medical records of pediatric HL patients (< 14 years) from 1975 through 2003 were retrospectively reviewed and the data analyzed.
Results: Stage IV patients (n = 67) had more poor-risk characteristics than patients in stages I-III (n = 300) (B symptoms 86.6% vs. 19.3%, bulky disease 57.6% vs. 45.5% and mediastinal mass 77.6% vs. 29.7%; P < .001 for all characteristics). The liver was the most common extralymphatic site (in 51.5% of patients with stage IV disease. Stage IV patients received chemotherapy (CT) alone (n = 55) or combined modality therapy (CMT) (n = 12). Fifty-four patients (80.6%) achieved complete remission, 2 (3%) partial remission, 10 (14.9%) had progressive disease and 1 was lost to follow up. Overall survival was 79.4% and event-free survival (EFS) was 63.9% at 5 years. There was a non-significant benefit for CMT (OS = 91.7% v. 77.1%, P = .3; EFS = 70.7% v. 62.7%, P = .3). Ten of 12 relapsed and only 1 of 10 progressive disease patients were salvaged. On multivariate analysis, failure to achieve complete remission with CT was associated with a poorer outcome.
Conclusion: Stage IV disease is associated with poor risk features and confers a worse outcome than stage I-III disease. Achievement of complete remission with CT is an important prognostic feature. Slow responders may require novel and/or aggressive therapy to achieve complete remission.
Publication (Name of Journal)
Hematology/Oncology and Stem Cell Therapy
Recommended Citation
Belgaumi, A.,
Al-Kofide, A. A.,
Khafaga, Y.,
Joseph, N.,
Jamil-Malik, R.,
Siddiqui, K. S.,
Sabbah, R. S.
(2009). Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy, 2(1), 278-284.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_med_haematol_oncol/124